image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Forterra

January 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FORT
  • Price:
  • 192p
Forterra has reported that its year to date sales volumes are in line with the prior year and full year results are expected to be in line with expectations. Group revenue was 23% ahead driven by three selling price increases, most recently 1 October when it raised brick prices 16.5% to recover cost inflation. It has secured almost 90% of its energy requirement for the remainder of 2022 and fixed 60% of its 2023 gas requirement (increased from c45% at the time of its last announcement). Forterra is heroically addressing capacity constraints by commissioning its new Desford brick factory on time, with the first bricks now extruded and the first of the two kilns now lit with bricks from the new factory for sale early in 2023 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X